Clinical trial Recruiting at 1 site Interventional Ages 19 and up

Comparing drug-coated balloon angioplasty versus drug-eluting stents for new coronary artery blockages

Official title: Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions

Run by Chonnam National University Hospital · NCT06954714 · Data updated 2026-11-12

This study will test whether drug-coated balloon angioplasty works as well as drug-eluting stents for adults with new coronary artery narrowings in vessels at least 3.0 mm wide.

More Coronary Artery Disease trials

Quick facts

Study typeInterventional
Ages19 Years and up
SexAll
Enrollment256 (estimated)
SponsorChonnam National University Hospital
Academic / other
Locations8 sites (Busan and 7 other locations)
StatusRecruiting
StartedAugust 18, 2025
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedOctober 22, 2026
Trial IDNCT06954714 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 19 or older with at least one de novo coronary lesion causing >50% diameter stenosis (or FFR ≤0.80) in a vessel ≥3.0 mm who can give informed consent.

Probably not a fit

Patients with left main disease, in-stent restenosis, target lesions in bypass grafts, true bifurcation lesions requiring upfront two-stent techniques, known intolerance to antiplatelet therapy, cardiogenic shock, or life expectancy under one year are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with de novo coronary artery stenosis in vessels ≥3.0 mm will receive either drug-coated balloon angioplasty or drug-eluting stent implantation, and artery changes will be measured using intravascular ultrasound (IVUS). The primary comparison is late-lumen loss (LLL) between the two approaches. The trial focuses on non-complex lesions eligible for percutaneous revascularization and records imaging and clinical outcomes over follow-up. The design compares a no-metal approach (DCB) that may allow shorter dual antiplatelet therapy against the current standard of a permanent metallic DES scaffold.

Why it matters

Potential benefit: If successful, drug-coated balloons could open arteries without leaving permanent metal behind and may allow shorter dual antiplatelet therapy, potentially lowering long-term stent-related risks.

How similar studies have gone: Prior randomized trials and meta-analyses support DCB use for in-stent restenosis and small-vessel de novo lesions, but results for larger or general de novo lesions have been mixed and non-inferiority to DES has not been consistently demonstrated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

1. Subject must be at least 19 years of age
2. Subject who is able to understand risks, benefits and treatment alternatives and sign informed consent voluntarily
3. Patients with at least one lesion with greater than 50% diameter stenosis or fractional flow reserve ≤0.80 requiring revascularization in de-novo coronary artery of reference vessel size ≥3.0 mm

Exclusion Criteria

1. Patients unable to provide consent
2. Patients with known intolerance to aspirin, P2Y12 inhibitors, or components of drug-eluting stents
3. Patients with angiographic findings of 1) Left main coronary artery disease 2) In-stent restenosis is the cause of target lesion 3) Target lesion in bypass graft 4) True bifurcation lesion that requires upfront 2-stenting
4. Patients who have non-cardiac co-morbid conditions with life expectancy \<1 year
5. Patients who may result in protocol non-compliance (site investigator's medical judgment)
6. Patients with cardiogenic shock or cardiac arrest
7. Patients with severe left ventricular systolic dysfunction (ejection fraction \<30%)
8. Patients with severe valvular heart disease requiring open heart surgery
9. Pregnant or lactating women

Where it's running

  • Chonnam National University
    Gwangju, South Korea
    Recruiting
  • Kosin University Gospel Hospital
    Busan, South Korea
    Not yet recruiting
  • Keimyung University Dongsan Hospital
    Daegu, South Korea
    Not yet recruiting
  • Jeonbuk National University Hospital
    Jeonju, South Korea
    Not yet recruiting
  • Samsung Medical Center
    Seoul, South Korea
    Not yet recruiting
  • Ewha Womans University Mokdong Hospital
    Seoul, South Korea
    Not yet recruiting
Show 2 more locations
  • Korea University Guro Hospital
    Seoul, South Korea
    Not yet recruiting
  • Ulsan University Hospital
    Ulsan, South Korea
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.